Skip to main content
Clinical Trials/NCT01527409
NCT01527409
Unknown
N/A

The Efficacy of Health Partnership Program for Cancer Patients

National Cancer Center, Korea10 sites in 1 country248 target enrollmentFebruary 2012

Overview

Phase
N/A
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
National Cancer Center, Korea
Enrollment
248
Locations
10
Primary Endpoint
Changes from Baseline in Exercise, Diet, and Posttraumatic Growth Inventory(PTGI)
Last Updated
14 years ago

Overview

Brief Summary

The Objectives of this study is

  1. To evaluate the efficacy for exercise, diet, and posttraumatic growth as a result of participating in tailored program (Health Partnership Program) for 24 weeks
  2. To evaluate the efficacy for quality of life, life satisfaction, health leadership, anxiety, depression, impact of event, social support, cancer belief as a result of participating in tailored program (Health Partnership Program) for 24 weeks
  3. To assess the efficacy of such intervention compared with usual care in cancer patients

Detailed Description

\*\*\*Background Improving cancer patients' quality of life has been increasing subject of research for several years. Especially, the patients and their families who are needed to deal with specific care on diverse aspects, such as social, spiritual, existential, psychological aspect should be provided integrated program. Multidimensional characteristics of the health partnership program were addressed in National Cancer Center (NCC) for exercise, diet, and posttraumatic growth based on transtheoretical (TTM) model, social cognitive theory, health behavioral model, and coaching strategies. This program points out the importance of behavioral approaches in managing their healthy life according to improve patterns of three areas (exercise, diet, and posttraumatic growth). Strategies that investigators mentioned above can lead those three areas to be effective. To objective of this study is to support cancer patients to cope with exercise, diet, and posttraumatic growth through tailored program (the health partnership program), and then evaluate the efficacy of the health partnership program. From evidence extracted from a literature review, contents of the program was elaborated, and tailored from the TTM model. The curriculum is currently being reviewed and validated by expert group of oncologists, nurse, psychologist and health education scientists. \*\*\*Method To determine the efficacy of the program (the health partnership program), a randomized controlled trial will be conducted: After excluding patients with other causes (anemia, thyroid disease, co morbidities etc), 248 patients will be recruited based on statistical assumption of alpha (0.05), beta (0.20=power 80%), and dropout rate (15%). First, patients will be stratified according to their age, sex (male vs. female), cancer types (stomach cancer, Breast cancer, cervical cancer, colorectal (except rectal cancer) cancer, and lung cancer), and then allocated to an intervention or control group. When intervention group participates in the tailored program (the health partnership program), they can receive various information which is related to health management and improving quality of life. The health partnership program consists of 16 time's tele-coaching, a self leadership workshop, and providing health materials (manuals, workbook, and booklet). Especially, those will be dealt with managing three areas; exercise, diet, and posttraumatic growth based on the transtheoretical model (TTM), social cognitive theory, health behavioral model, and coaching strategies. Cancer patients who are participated in the tailored program will be received tailored feedbacks that enhance participants of the next level of the program. On the other hand, the control group could not participate in the health partnership program. The control group could only be treated by usual care and a health education workshop with a health booklet. However, the control group can participate in the health partnership program after 12 month. Data will be collected before randomization, after intervention, and after a follow-up of 3, 6, and 12 months.

Registry
clinicaltrials.gov
Start Date
February 2012
End Date
June 2013
Last Updated
14 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

YoungSung Lee

Head, Division of Cancer Management Branch

National Cancer Center, Korea

Eligibility Criteria

Inclusion Criteria

  • Adult(≥ 20 years)
  • Within 24 months of completion of primary treatment with curative intent (Surgery, radiotherapy, chemotherapy)
  • Breast, cervical, colorectal (except rectal cancer), lung, and stomach cancer
  • More than two problematic areas among exercise, diet (Fruit \& Vegetable: F\&V), and posttraumatic growth(exercise \< 150min/week, ≥ 3mets, F\&V \< 5/day, PTGI \< 71)

Exclusion Criteria

  • Evidence of secondary tumor, metastasis and recurrence
  • Patients undergoing or planning surgery, radiation therapy or chemotherapy
  • Not Korean speaking and reading (Not communication with Korean)
  • Not understanding of the study purpose and not written informed consent
  • Participants who have an similar study experience
  • Major health problem in which exercise/nutrition intervention is contraindicated at the discretion of clinician; cardiovascular disease (congestive heart failure, angina), pulmonary disease (chronic obstructive pulmonary disease, restrictive pulmonary disease), uncontrolled hypertension, poorly controlled diabetes and severe musculoskeletal disease and so on
  • Sign of infection (body temperature ≥ 37.2℃ or WBC ≥ 11,000)
  • Being pregnant
  • Thrombocytopenia (platelet count ≤ 100,000/mcl)
  • Anemia (Hb ≤ 10g/dL)

Outcomes

Primary Outcomes

Changes from Baseline in Exercise, Diet, and Posttraumatic Growth Inventory(PTGI)

Time Frame: baseline, 3month, 6month, and 12month

How much the patient does exercise will be measured using "MET" score. Change in diet will be observed by analyzing 3day recall.

Secondary Outcomes

  • Social Support(MOS-SSS)(baseline, after 3month, 6month, and 12month)
  • Cancer Belief System(CBS)(baseline, after 3month, 6month, and 12month)
  • Seven habit profile(baseline, 3month, 6month, and 12month)
  • the European Organisation for the Research and Treatment of Cancer Quality-of-life Questionnaire-Core 30(EORTC QLQ C-30)(baseline, after 3month, 6month, and 12month)
  • Ed Diner's Satisfaction with Life Scale(baseline, after 3month, 6month, and 12month)
  • Impact of Event Scale-Revised(baseline, after 3month, 6month, and 12month)
  • the Hospital Anxiety and Depression scale(HADS)(baseline, after 3month, 6month, and 12month)

Study Sites (10)

Loading locations...

Similar Trials